Literature DB >> 128533

Experimental immune complex glomerulopathy: immunomorphological aspects and correlations with human disease.

P Rossmann, I Ríha, I Hajdu.   

Abstract

Thirteen rabbits received parenteral injections of human serum albumin (HSA) in regular doses and intervals during 6-32 seeks. The antigen load elicited immune responses of variable degree, giving a good correlation with the extent and quality of immune complex (IMC) deposition, as shown by immunological methods, electron and fluorescence microscopy and by histoautoradiography. Morphology of immune deposits (IMD) depended on the composition of the IMC and produced a continuous scale of glomerular involvement, ranging from minimal and focal to massive and diffuse deposition. Probable rudimentary traces of IMD were apparent in the ultrastructure even in animals with negative results of both immunological and immunfluorescence examinations. The relationships are discussed between experimental IMC-induced glomerulopathy on the one hand, and some problems of development and bioptic evaluation of human glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 128533     DOI: 10.1007/bf02082678

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  32 in total

1.  Renal morphological and immunological changes associated with acute viral hepatitis.

Authors:  G Eknoyan; F Györkey; C Dichoso; M Martinez-Maldonado; W N Suki; P Györkey
Journal:  Kidney Int       Date:  1972-06       Impact factor: 10.612

2.  Study of human renal disease by immunofluorescent methods.

Authors:  W K Hadley; W Rosenau
Journal:  Arch Pathol       Date:  1967-04

3.  Mesangial and subepithelial localization of ferritin immune complexes in mouse glomerulus.

Authors:  V E Kelley; R S Cotran
Journal:  Lab Invest       Date:  1972-07       Impact factor: 5.662

4.  Experimental immunologic glomerulonephritis.

Authors:  F J Dixon; C B Wilson; H Marquardt
Journal:  Adv Nephrol Necker Hosp       Date:  1971

5.  "Hyperacute" renal-homograft rejection in man.

Authors:  G M Williams; D M Hume; R P Hudson; P J Morris; K Kano; F Milgrom
Journal:  N Engl J Med       Date:  1968-09-19       Impact factor: 91.245

6.  Influence of preexistent pyelonephritis on the development and manifestations of acute fatal glomerulonephritis.

Authors:  P Rossmann; J Hurych
Journal:  Int Urol Nephrol       Date:  1973-01       Impact factor: 2.370

7.  [Anatomoclinical study of extramembraneous glomerulonephritis].

Authors:  H Ducrot; C Tsomi; P Jungers; H de Montera; N Hinglais; M Giromini
Journal:  J Urol Nephrol (Paris)       Date:  1969-09

8.  Glomerulonephritis associated with (infected) ventriculo-atrial shunt.

Authors:  W Wegmann; E P Leumann
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1973-05-28

9.  Immune complex disease. I. Experimental acute and chronic glomerulonephritis.

Authors:  F G Germuth; L B Senterfit; A D Pollack
Journal:  Johns Hopkins Med J       Date:  1967-04

10.  Glomerulonephritis with - and 1C-globulin deposits induced in rats by mercuric chloride.

Authors:  J Bariety; P Druet; F Laliberte; C Sapin
Journal:  Am J Pathol       Date:  1971-11       Impact factor: 4.307

View more
  3 in total

1.  Experimental glomerular lesions induced by chronic immune complex formation. I. Formation and elimination of the immune complex (relationship between the immune status and the glomerular changes).

Authors:  T Szabó; J Szabó; C Balázs; G Lustyik
Journal:  Int Urol Nephrol       Date:  1979       Impact factor: 2.370

2.  Experimental glomerular lesions induced by chronic immune complex formation. II. Pathomorphological analysis.

Authors:  J Szabó; T Szabó; T Tóth; G Lustyik; C Balázs
Journal:  Int Urol Nephrol       Date:  1979       Impact factor: 2.370

3.  Experimental studies on factors causing acute serum sickness glomerulonephritis of immune complex origin. II. Pathomorphological analysis.

Authors:  J Szabó; T Szabó; G Lustyik; A Lenkey
Journal:  Int Urol Nephrol       Date:  1977       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.